Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
AI In Life Science Analytics Market Expansion From $3.13 Billion In 2026 To $6.16 Billion In 2030
The artificial intelligence market within life science analytics has witnessed substantial expansion over the recent past. Projected to increase from $2.63 billion in 2025 to $3.13 billion in 2026, it is growing at a compound annual growth rate (CAGR) of 19.0%. This historical surge can be credited to a larger amount of clinical and research data, a rise in digital clinical trials, greater utilization of analytics for pharmaceutical research and development, a shift toward data-based decision-making in the life sciences field, and enhancements in data integration technologies.
The market for AI in life science analytics is projected to experience significant expansion in the coming years, with its value anticipated to reach $6.16 billion by 2030, reflecting a compound annual growth rate (CAGR) of 18.4%. This forecasted growth is fueled by a rising demand for precision diagnostics, increased investments in AI-powered drug development, broader adoption of cloud-based analytics, expanded use of real-world evidence analytics, and a stronger emphasis on operational efficiency within the life sciences sector. Key trends shaping this period include the growing implementation of AI-driven clinical analytics tools, the increasing application of predictive modeling in drug discovery, the widespread uptake of cloud-based solutions for life science analytics, the development of advanced real-time data integration platforms, and a heightened focus on generating actionable insights.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9850&type=smp
#AI In Life Science Analytics Market Growth Factors: Which Forces Are Supporting Market Expansion?
The expansion of the AI in life science analytics market is expected to be driven forward by increasing healthcare spending. This spending refers to the overall monetary investment in healthcare goods and services during a given timeframe, covering a wide array of expenses linked to medical treatments and public health efforts. Such rising costs are fueled by the growing occurrence of chronic and lifestyle-related illnesses, which demand extended care, ongoing medical attention, and pricey treatments. By funding sophisticated data-driven technologies, healthcare expenditure encourages the integration of AI in life science analytics, enhancing research efficiency, patient results, and affordable healthcare options. For example, as reported by the Office of National Statistics, a UK government agency, total healthcare spending saw a 5.6% nominal increase from 2022 to 2023, following a 0.9% growth in 2022. Consequently, the upward trend in healthcare costs is propelling the advancement of AI within the life science analytics market.
AI In Life Science Analytics Market Segment Breakdown: Which Categories Generate The Most Revenue?
The AI in life science analytics market covered in this report is segmented –
1) By Component: Software, Hardware, Services
2) By Deployment: On-Premise, Cloud
3) By Application: Research And Development, Sales And Marketing Support, Supply Chain Analytics, Other Applications
4) By End-User: Medical Devices, Pharmaceutical, Biotechnology, Other End Users
Subsegments:
1) By Software: Data Analysis Software, Predictive Analytics Tools, Machine Learning Platforms, Visualization Software, Clinical Trial Management Software
2) By Hardware: Servers, Storage Solutions, Workstations, Networking Equipment
3) By Services: Consulting Services, Integration Services, Support And Maintenance, Data Management Services, Training Services
AI In Life Science Analytics Market Industry Trends: What Changes Are Reshaping Demand?
Major players within the AI in Life Science Analytics market are concentrating their efforts on creating innovative tools, with particular emphasis on AI-powered multi-omics data analysis platforms designed to enhance precision and accelerate discoveries in biomedical research. Such a platform leverages artificial intelligence to combine and interpret various biological data types—including genomics, proteomics, and metabolomics—thereby revealing intricate biological patterns and facilitating precision medicine. A concrete example of this trend occurred in October 2023, when BioLizard, a Belgian biotechnology company, introduced its new AI-driven BioVerse platform, aimed at enabling data-focused research and development for the global life sciences community. This platform delivers customizable, user-centric software solutions that cater to scientists in biotech and pharmaceutical sectors, regardless of their IT proficiency. Among its offerings are three distinct applications: Bio|Reflect, which generates comprehensive publication overviews to assist in objective literature searches; Pro|Biome, utilizing data analytics for microbiome investigation; and Bio|Mx, which employs AI to merge and examine multi-omics datasets. Ultimately, BioVerse’s mission is to promote data-enabled discovery and optimize preclinical, translational, and clinical R&D operations within the life sciences sector through the implementation of AI-centric solutions. This product launch underscores BioLizard’s dedication to delivering AI-based tools that support data-driven discovery and preclinical, translational, and clinical R&D functions in the life sciences industry.
AI In Life Science Analytics Market Key Players And Strategic Industry Positioning
Major companies operating in the AI in life science analytics market are Indegene Limited; International Business Machines Corporation; IQVIA Holdings Inc.; Databricks Inc.; SAS Institute Inc.; Sorcero; Atomwise Inc.; Microsoft Corporation; NVIDIA Corporation; Oracle Corporation; NuMedii Inc.; Enlitic Inc.; Apixio Inc.; AiCure LLC; Google LLC; Amazon Web Services Inc.; Accenture; BioSymetrics; Cloud Pharmaceuticals; Freenome; GNS Healthcare; Insilico Medicine; PathAI; Recursion Pharmaceuticals; Sophia Genetics; Veracyte Inc.; Lexalytics Inc.; Sisense Inc.; Cognitivescale; Ayasdi; Cyrcadia Health
Access The Complete AI In Life Science Analytics Market Report:
https://www.thebusinessresearchcompany.com/report/ai-in-life-science-analytics-global-market-report
AI In Life Science Analytics Market Regional Outlook: Where Are The Largest Opportunities Located?
North America was the largest region in the AI in life science analytics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the AI in life science analytics market report during the forecast period. The regions covered in the AI in life science analytics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Customized AI In Life Science Analytics Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=9850&type=smp
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.